HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Han Li Selected Research

sulindac sulfone (exisulind)

7/2008Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
11/2002Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
11/2002beta-Catenin signaling: therapeutic strategies in oncology.
8/2002Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Han Li Research Topics

Disease

76Neoplasms (Cancer)
09/2022 - 11/2002
18COVID-19
06/2022 - 01/2020
18Inflammation (Inflammations)
04/2022 - 01/2016
18Infections
01/2022 - 10/2006
13Neoplasm Metastasis (Metastasis)
01/2021 - 01/2012
11Breast Neoplasms (Breast Cancer)
02/2022 - 01/2005
9Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 01/2013
8Atherosclerosis
06/2022 - 01/2014
8Hemorrhage
01/2022 - 09/2014
8Colonic Neoplasms (Colon Cancer)
11/2020 - 01/2002
7Lung Neoplasms (Lung Cancer)
06/2022 - 12/2011
7Anthrax
01/2020 - 10/2004
6Insulin Resistance
05/2022 - 01/2018
6Non-alcoholic Fatty Liver Disease
04/2022 - 01/2018
6Anemia
01/2020 - 01/2008
6Glioma (Gliomas)
01/2020 - 10/2018
5Obesity
06/2022 - 01/2018
5Carcinogenesis
01/2022 - 09/2014
5Body Weight (Weight, Body)
09/2021 - 11/2015
5Lymphatic Metastasis
01/2021 - 10/2016
4Chronic Renal Insufficiency
11/2022 - 01/2021
4Hypertension (High Blood Pressure)
06/2022 - 03/2011
4Fatigue
05/2022 - 07/2019
4Wounds and Injuries (Trauma)
05/2022 - 12/2020
4Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 01/2010
4Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2018
4Carcinoma (Carcinomatosis)
09/2021 - 07/2017
4Necrosis
07/2021 - 01/2013
4Brucellosis (Malta Fever)
01/2021 - 01/2016
4Pain (Aches)
01/2021 - 01/2015
4Diabetic Nephropathies (Diabetic Nephropathy)
03/2018 - 01/2010
3Cognitive Dysfunction
11/2022 - 01/2021
3Liver Diseases (Liver Disease)
08/2022 - 01/2022
3Epilepsy (Aura)
06/2022 - 04/2020
3Human Influenza (Influenza)
06/2022 - 01/2010
3Drug-Related Side Effects and Adverse Reactions
06/2022 - 01/2021
3Ulcerative Colitis
04/2022 - 12/2020
3Stomach Neoplasms (Stomach Cancer)
04/2022 - 06/2017
3Virus Diseases (Viral Diseases)
01/2022 - 12/2010
3Heart Failure
01/2022 - 10/2008
3Osteoarthritis
01/2022 - 01/2012
3Myocardial Infarction
01/2022 - 01/2019
3Stroke (Strokes)
01/2022 - 10/2021
3Hepatitis
01/2022 - 07/2019
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 09/2018
3Fibrosis (Cirrhosis)
09/2021 - 10/2006
3Glucose Intolerance
09/2021 - 09/2020
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 12/2017

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
09/2022 - 01/2002
15Biological ProductsIBA
02/2022 - 06/2012
15Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2006
13Messenger RNA (mRNA)IBA
01/2022 - 01/2012
13AntigensIBA
09/2021 - 10/2004
9Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 03/2014
9LipidsIBA
05/2022 - 01/2020
9Pharmaceutical PreparationsIBA
01/2022 - 11/2012
9RNA (Ribonucleic Acid)IBA
03/2021 - 01/2002
8Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2018
7CytokinesIBA
10/2022 - 09/2014
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2011
6CateninsIBA
06/2022 - 03/2018
6Long Noncoding RNAIBA
11/2020 - 06/2017
5C-Reactive ProteinIBA
10/2022 - 01/2017
5Retinaldehyde (Retinal)IBA
10/2022 - 12/2012
5MicroRNAs (MicroRNA)IBA
01/2021 - 12/2017
5Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2020 - 01/2014
5Immunoglobulin G (IgG)IBA
01/2017 - 10/2004
4Indicators and Reagents (Reagents)IBA
05/2022 - 01/2011
4remdesivirIBA
01/2022 - 09/2020
4Uric Acid (Urate)IBA
01/2022 - 01/2020
4EnzymesIBA
01/2022 - 07/2008
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2011
4Therapeutic UsesIBA
01/2022 - 09/2020
4salicylhydroxamic acid (SHAM)IBA
08/2021 - 12/2013
4Interleukin-6 (Interleukin 6)IBA
05/2021 - 01/2018
4AntibodiesIBA
11/2020 - 01/2017
4triptolideIBA
11/2020 - 12/2011
4LuciferasesIBA
01/2020 - 01/2019
4anthrax toxin (anthrax lethal factor)IBA
01/2016 - 10/2004
4sulindac sulfone (exisulind)IBA
07/2008 - 08/2002
3InflammasomesIBA
08/2022 - 01/2021
3SolutionsIBA
06/2022 - 10/2016
3TriterpenesIBA
01/2022 - 06/2012
3Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2020
3Hemoglobins (Hemoglobin)IBA
12/2021 - 03/2011
3NF-kappa B (NF-kB)IBA
11/2021 - 08/2017
3Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 11/2012
3Antiviral Agents (Antivirals)IBA
09/2021 - 09/2020
3AlkaloidsIBA
09/2021 - 01/2018
3Caspase 1 (ICE Protease)IBA
09/2021 - 01/2021
3Insulin (Novolin)FDA Link
09/2021 - 01/2020
3VaccinesIBA
04/2021 - 01/2020

Therapy/Procedure

34Therapeutics
06/2022 - 11/2002
19Renal Dialysis (Hemodialysis)
11/2022 - 01/2008
11Drug Therapy (Chemotherapy)
01/2022 - 08/2015
9Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2022 - 01/2016
5Kidney Transplantation
01/2022 - 12/2010
4Liver Transplantation
01/2021 - 01/2016
4Peritoneal Dialysis
01/2014 - 02/2008
3Radiotherapy
04/2021 - 05/2017